NIH/ NCI 352 Yes No No Cell and Animal-Based Models to Advance Cancer Health Disparity Research NIH/ NCI 353 Yes Yes No Cell-Free Nucleic Acid-Based Assay Development for Cancer Diagnosis NIH/ NCI 354 Yes Yes No Companion Diagnostics for Cancer Immunotherapies NIH/ NCATS 013 Yes No No Development of Stem Cell-based Assay for Screening of Chemicals of Toxicological Concern NIH/ NCATS 014 Yes No No Development of Smart Plate Technology NIH/ NHLBI 094 Yes Yes Yes Transcatheter Cavopulmonary Bypass Endograft NIH/ NHLBI 095 Yes Yes Yes Active MRI Transseptal Needle NIH/ NHLBI 096 Yes Yes Yes Bioabsorbable Stents for Neonatal Aortic Coarctation NIH/ NHLBI 097 Yes Yes Yes Early Detection and Monitoring of Cardiac Injury Due to Cardiotoxicity NIH/ NIAAA 015 Yes No No Development of Novel Compounds to Treat Alcohol Use Disorder NIH/ NIAID 033 Yes Yes No Precision Genome Engineering for HIV Eradication NIH/ NIAID 034 Yes Yes No High-Throughput Assay Platform for Quantifying Latent HIV Reservoirs NIH/ NIAID 035 Yes Yes Yes Method for the Detection of Minority Populations of Drug Resistant HIV NIH/ NIAID 036 Yes Yes Yes Simple, Inexpensive Device to Purify DNA from Sputum for Tuberculosis Testing NIH/ NIAID 037 Yes Yes Yes Telemonitoring for Infectious Diseases: A Remote System for Assessing Patient Parameters and Specimen Analysis NIH/ NIAID 038 Yes Yes Yes Innovative Oral Formulations for Anti-Infective Drugs
NIH/ NIAID 039 Yes Yes No Vaccines against Pathogens with Small Market Potential NIH/ NIDA 158 Yes No No Development of Primer and Reference Tool to Assess Neonatal Abstinence Syndrome NIH/ NIDA 159 Yes No No Therapeutic Cannabidiol Pulmonary Delivery Device (e.g. Nebulizer, Vaporizer, or Inhaler) NIH/ NIDA 160 Yes No No “The Pain Mobile:” Remote Pain Management System CDC/ CGH 008 Yes No No Diagnostic Tools to Support the Elimination and Control of Neglected Tropical Diseases CDC/ NCEZID 012 Yes No No De novo assembly of arthropod genomes of public health importance CDC/ NCEZID 013 Yes No No Detecting Lower Intestinal Microbiome Disruption and Multidrug Resistant Organisms CDC/ NCHHSTP 046 Yes No No Serologic measurement of hepatitis B virus cccDNA CDC/ NCHHSTP 047 Yes No No Serologic detection and quantification of hepatitis B core antigen CDC/ NCIRD 031 Yes No No Transcutaneous immunization against rotavirus using a dissolvable microneedle patch CDC/ NCIRD 032 Yes No No Thermostable Dry Powder Live Attenuated Influenza Vaccine for Nasal Delivery All firms that are awarded Phase I contracts originating from this solicitation will be eligible to participate in Phases II and III. HHS Components will notify Phase I awardees of the Phase II proposal submission requirements. Submission of Phase II proposals will be in accordance with dates provided by individual Component instructions. The details on the due date, content, and submission requirements of the Phase II proposal will be provided by the awarding HHS Component either in the Phase I award or by subsequent notification. The HHS is not obligated to make any awards under Phase I, Phase II, or Phase III, and all awards are subject to the availability of funds. HHS is not responsible for any monies expended by the offeror before award of any contract.